Cipla Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
819 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for UTEKNIX Ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for UTEKNIX Ustekinumab 90 mg/1 mL solution for injection pre-filled syringe.
-
Prescription medicine registrationActive ingredients: Liraglutide.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2025
-
Prescription medicine registrationActive ingredients: Ustekinumab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA TERIPARATIDE teriparatide 250 microgram/mL solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPLA FOSFOMYCIN fosfomycin (as trometamol) 3 g granules for oral solution sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CIPFOSIN fosfomycin (as trometamol) 3 g granules for oral solution sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LEVETIRACETAM-WGR levetiracetam 500 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LEVETIRACETAM-WGR levetiracetam 250 mg film coated tablet blister pack.